Literature DB >> 33485300

Associations between hyperhomocysteinemia and the presence and severity of acute coronary syndrome in young adults ≤ 35 years of age.

Jiayin Sun1, Wei Han1, Sijing Wu1, Shuo Jia1, Zhenxian Yan1, Yonghe Guo1, Yingxin Zhao1, Yujie Zhou1, Wei Liu2.   

Abstract

BACKGROUND: The prevalence of acute coronary syndrome (ACS) continues to increase among young Chinese adults. Homocysteine (HCY) has been suggested as a promoter of atherosclerosis leading to coronary artery disease (CAD). Yet, it remains uncertain whether HCY is associated with the ACS and the severity of coronary artery stenosis in young adults.
METHODS: Young patients (18-35 years of age) diagnosed with ACS who underwent coronary angiography (CAG) at Anzhen Hospital between January 2013 and June 2019 were assigned to the ACS group. As confirmed by CAG during the same period, an equivalent age-matched population without CAD was assigned to the non-CAD group. A serum HCY level > 15 µmol/L was defined as hyperhomocysteinemia (HHCY). The Gensini score assessed the severity of coronary artery stenosis.
RESULTS: A total of 1103 participants, including 828 ACS patients and 275 non-CAD subjects, were enrolled in this study. Young ACS patients had higher level of serum HCY and greater prevalence of HHCY compared with non-CAD subjects [for HCY, 16.55 (11.93-29.68) vs 12.50 (9.71-17.42), P < 0.001; for HHCY prevalence, 62.08% vs 26.18%, P < 0.001]. Multivariate logistic regression analysis with the stepwise method indicated that HHCY was an independent predictor associated with the presence of ACS, after adjusting for traditional confounders (OR, 4.561; 95% CI, 3.288-6.327; P < 0.001). Moreover, young ACS patients with HHCY had increased prevalence of ST-segment elevation myocardial infarction (STEMI) (P = 0.041), multi-vessel disease (P = 0.036), and decreased value of left ventricular ejection fraction (LVEF) (P = 0.01). Also, the HCY level was significantly correlated with Gensini Score in ACS patients (r = 0.142, P < 0.001).
CONCLUSION: HHCY is significantly associated with the presence of ACS and the severity of coronary artery stenosis in young adults ≤ 35 years of age.

Entities:  

Keywords:  Acute coronary syndrome; Hyperhomocysteinemia; Severity; Young

Year:  2021        PMID: 33485300      PMCID: PMC7825206          DOI: 10.1186/s12872-021-01869-y

Source DB:  PubMed          Journal:  BMC Cardiovasc Disord        ISSN: 1471-2261            Impact factor:   2.298


  39 in total

1.  Determination of Serum Homocysteine and Hypersensitive C-reactive Protein and Their Correlation with Premature Coronary Heart Disease.

Authors:  Songsen Li; Guangjie Pan; Huili Chen; Xiaohua Niu
Journal:  Heart Surg Forum       Date:  2019-05-22       Impact factor: 0.676

2.  [Fifteen-year trend in incidence of acute myocardial infarction in Tianjin of China].

Authors:  D Z Wang; C F Shen; Y Zhang; H Zhang; G D Song; W Li; X D Xue; Z L Xu; S Zhang; G H Jiang
Journal:  Zhonghua Xin Xue Guan Bing Za Zhi       Date:  2017-02-24

3.  Caring for Coronary Artery Disease in China: Managing Modernization.

Authors:  David Blumenthal; William Hsiao; Daniel M Blumenthal
Journal:  JAMA Intern Med       Date:  2016-04       Impact factor: 21.873

4.  Relationship between homocysteine and coronary artery disease. Results from a large prospective cohort study.

Authors:  Alon Schaffer; Monica Verdoia; Ettore Cassetti; Paolo Marino; Harry Suryapranata; Giuseppe De Luca
Journal:  Thromb Res       Date:  2014-05-27       Impact factor: 3.944

Review 5.  The current status of homocysteine as a risk factor for cardiovascular disease: a mini review.

Authors:  Steven G Chrysant; George S Chrysant
Journal:  Expert Rev Cardiovasc Ther       Date:  2018-07-17

6.  Incidence, risk factors and outcome of young patients with myocardial infarction.

Authors:  Jarle Jortveit; Are Hugo Pripp; Jørund Langørgen; Sigrun Halvorsen
Journal:  Heart       Date:  2020-02-28       Impact factor: 5.994

7.  2007 ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mansia; Guy De Backer; Anna Dominiczak; Renata Cifkova; Robert Fagard; Giuseppe Germano; Guido Grassi; Anthony M Heagerty; Sverre E Kjeldsen; Stephane Laurent; Krzysztof Narkiewicz; Luis Ruilope; Andrzej Rynkiewicz; Roland E Schmieder; Harry A Struijker Boudier; Alberto Zanchetti
Journal:  Blood Press       Date:  2007       Impact factor: 2.835

8.  Associations between Serum 25-hydroxyvitamin D and Lipids, Lipoprotein Cholesterols, and Homocysteine.

Authors:  Charles J Glueck; Vybhav Jetty; Matan Rothschild; Gregory Duhon; Parth Shah; Marloe Prince; Kevin Lee; Michael Goldenberg; Ashwin Kumar; Naila Goldenberg; Ping Wang
Journal:  N Am J Med Sci       Date:  2016-07

9.  Trend in young coronary artery disease in China from 2010 to 2014: a retrospective study of young patients ≤ 45.

Authors:  Xin Wang; Ming Gao; Shanshan Zhou; Jinwen Wang; Fang Liu; Feng Tian; Jing Jin; Qiang Ma; Xiaodi Xue; Jie Liu; Yuqi Liu; Yundai Chen
Journal:  BMC Cardiovasc Disord       Date:  2017-01-07       Impact factor: 2.298

10.  Guidelines for Diagnosis and Treatment of Familial Hypercholesterolemia 2017.

Authors:  Mariko Harada-Shiba; Hidenori Arai; Yasushi Ishigaki; Shun Ishibashi; Tomonori Okamura; Masatsune Ogura; Kazushige Dobashi; Atsushi Nohara; Hideaki Bujo; Katsumi Miyauchi; Shizuya Yamashita; Koutaro Yokote
Journal:  J Atheroscler Thromb       Date:  2018-06-07       Impact factor: 4.928

View more
  2 in total

1.  Combined effect of hyperhomocysteinemia and smoking on the severity of coronary artery disease in young adults ≤ 35 years of age: a hospital-based observational study.

Authors:  Jiayin Sun; Wei Han; Sijing Wu; Shuo Jia; Zhenxian Yan; Yonghe Guo; Yingxin Zhao; Yujie Zhou; Xiaoli Liu
Journal:  BMC Cardiovasc Disord       Date:  2021-10-09       Impact factor: 2.298

2.  Hyperhomocysteinemia presenting as exclusive small vessel coronary artery disease (CAD) in a young.

Authors:  Debasish Das; Tutan Das; Subhas Pramanik
Journal:  J Family Med Prim Care       Date:  2022-06-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.